Teva Pharmaceutical Industries Limited (TEVJF)
OTCMKTS · Delayed Price · Currency is USD
28.36
0.00 (0.00%)
At close: Jan 26, 2026
Teva Pharmaceutical Industries Employees
Teva Pharmaceutical Industries had 37,000 employees as of June 30, 2025. The number of employees did not change compared to the same quarter last year.
Employees
37,000
Change
n/a
Growth
n/a
Revenue / Employee
$539,178
Profits / Employee
$44,051
Market Cap
40.02B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jun 30, 2025 | 37,000 | 0 | - | 37,000 | 0 |
| Mar 31, 2025 | 37,000 | 528 | 1.45% | 37,000 | 0 |
| Dec 31, 2024 | 35,686 | -786 | -2.16% | 33,892 | 1,794 |
| Sep 30, 2024 | 37,000 | 528 | 1.45% | 37,000 | 0 |
| Dec 31, 2023 | 36,472 | 1,347 | 3.83% | 35,001 | 1,471 |
| Dec 31, 2022 | 35,125 | -854 | -2.37% | 34,004 | 1,121 |
| Dec 31, 2021 | 35,979 | -2,393 | -6.24% | 34,713 | 1,266 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Jushi Holdings | 1,234 |
| MariMed | 832 |
| Glass House Brands | 374 |
| Earth Science Tech | 76 |
| Elite Pharmaceuticals | 68 |
| Radnostix | 42 |
| Healthy Extracts | 2 |
Teva Pharmaceutical Industries News
- 12 days ago - Novo sued for working with Teva to delay generic Victoza - Seeking Alpha
- 14 days ago - FINANCIAL CONSULATE, INC Buys 270 Shares of Teva Pharmaceutical Industries Ltd (TEVA) - GuruFocus
- 15 days ago - Tema Heart & Health ETF Buys 9,762 Shares of Teva Pharmaceutical Industries Ltd (TEVA) - GuruFocus
- 15 days ago - ESGD, SPOT, SE, TEVA: Large Outflows Detected at ETF - Nasdaq
- 15 days ago - Independence Bank of Kentucky Buys 66 Shares of Teva Pharmaceutical Industries Ltd (TEVA) - GuruFocus
- 22 days ago - Teva (TEVA) Gains FDA Approval for Ajovy in Pediatric Migraine Treatment - GuruFocus
- 22 days ago - AJOVY® (fremanezumab-vfrm) Significantly Reduced Monthly Migraine and Headache Days in Children and Adolescents with Episodic Migraine Compared to Placebo in the SPACE Trial; Results Published in New England Journal of Medicine - GlobeNewsWire
- 22 days ago - Teva Is No Longer A Turnaround Story, It's A Growth One - Seeking Alpha